Leukemia & Lymphoma, Volume 59, Issue 3 (2018)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 59, Issue 3 (2018)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Volume 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Chronic lymphocytic leukemia is becoming more complex: how to define complex karyotype?
Natalia Kreinitz, Aaron Polliack & Tamar Tadmor
Pages: 521-522
Published online: 18 Sep 2017
CitationforChronic lymphocytic leukemia is becoming more complex: how to define complex karyotype? | Full Text | References | PDF (242.8 KB) | Supplemental
  • 228 Views
  • 2 CrossRef citations
  • 0Altmetric
Interim PET in lymphoma: from Deauville to Peking criteria. On the road, again…
Michel Meignan & Anne-Ségolène Cottereau
Pages: 523-525
Published online: 30 Aug 2017
First Page PreviewforInterim PET in lymphoma: from Deauville to Peking criteria. On the road, again… | Full Text | References | PDF (255.5 KB)
  • 311 Views
  • 5 CrossRef citations
  • 0Altmetric

Reviews

Continuing challenges and current issues in acute lymphoblastic leukemia
Ankit Kansagra, Saurabh Dahiya & Mark Litzow
Pages: 526-541
Published online: 11 Jun 2017
AbstractforContinuing challenges and current issues in acute lymphoblastic leukemia | Full Text | References | PDF (2 MB) | Supplemental
  • 1363 Views
  • 20 CrossRef citations
  • 0Altmetric
Overcoming multiple myeloma drug resistance in the era of cancer ‘omics’
Matthew Ho Zhi Guang, Amanda McCann, Giada Bianchi, Li Zhang, Paul Dowling, Despina Bazou, Peter O’Gorman & Kenneth C. Anderson
Pages: 542-561
Published online: 13 Jun 2017
AbstractforOvercoming multiple myeloma drug resistance in the era of cancer ‘omics’ | Full Text | References | PDF (1.6 MB) | Supplemental
  • 1119 Views
  • 28 CrossRef citations
  • 0Altmetric
Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome
Jenna Janiga, Jonathan Kentley, Chadi Nabhan & Farah Abdulla
Pages: 562-577
Published online: 08 Jan 2018
AbstractforCurrent systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome | Full Text | References | PDF (1.2 MB) | Supplemental
  • 592 Views
  • 15 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Recommendations for skin cancer monitoring for patients with chronic lymphocytic leukemia
Anthea Mulcahy, Stephen P. Mulligan & Stephen P. Shumack
Pages: 578-582
Published online: 03 Aug 2017
First Page PreviewforRecommendations for skin cancer monitoring for patients with chronic lymphocytic leukemia | Full Text | References | PDF (426.6 KB)
  • 254 Views
  • 11 CrossRef citations
  • 0Altmetric
Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria
Guillemette Fouquet, Kym IE Snell, Stéphanie Guidez, Susanna Schraen, Eileen Boyle, Loïc Renaud, Déborah Desmier, Antoine Machet, Niels Moya, Thomas Systchenko, Cécile Gruchet, Olivier Decaux, Bertrand Arnulf, Cécile Fohrer, Valentine Richez, Brigitte Kolb, Margaret Macro, Lionel Karlin, Bruno Royer, Brigitte Pegourie, Benjamin Hebraud, Denis Caillot, Aurore Perrot, Philippe Moreau, Thierry Facon, Hervé Avet-Loiseau, Thomas Dejoie, Cyrille Hulin, Stephen Harding & Xavier Leleu
Pages: 583-589
Published online: 12 Jul 2017
AbstractforHeavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria | Full Text | References | PDF (683.4 KB) | Supplemental
  • 358 Views
  • 3 CrossRef citations
  • 0Altmetric
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation
Federico Simonetta, Stavroula Masouridi-Levrat, Yan Beauverd, Olga Tsopra, Yordanka Tirefort, Aikaterini Koutsi, Caroline Stephan, Karolina Polchlopek-Blasiak, Amandine Pradier, Carole Dantin, Marc Ansari, Eddy Roosnek & Yves Chalandon
Pages: 590-600
Published online: 06 Jul 2017
AbstractforPartial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation | Full Text | References | PDF (1.2 MB) | Supplemental
  • 233 Views
  • 3 CrossRef citations
  • 0Altmetric
Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients
Masamitsu Yanada, Jinichi Mori, Jun Aoki, Kaito Harada, Shohei Mizuno, Naoyuki Uchida, Saiko Kurosawa, Takashi Toya, Heiwa Kanamori, Yukiyasu Ozawa, Hiroyasu Ogawa, Hideho Henzan, Koji Iwato, Toru Sakura, Shuichi Ota, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta & Shingo Yano
Pages: 601-609
Published online: 28 Jul 2017
AbstractforEffect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients | Full Text | References | PDF (1.2 MB) | Supplemental
  • 348 Views
  • 39 CrossRef citations
  • 0Altmetric
Acute myeloid leukemia during pregnancy: a systematic review and meta-analysis
Netanel A. Horowitz, Israel Henig, Oryan Henig, Noam Benyamini, Liat Vidal & Irit Avivi
Pages: 610-616
Published online: 13 Jul 2017
AbstractforAcute myeloid leukemia during pregnancy: a systematic review and meta-analysis | Full Text | References | PDF (660.1 KB) | Supplemental
  • 1058 Views
  • 19 CrossRef citations
  • 0Altmetric
PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia
Caitlin R. Rausch, Bernard L. Marini, Lydia L. Benitez, Allison Elias, Patrick W. Burke, Dale Bixby & Anthony J. Perissinotti
Pages: 617-624
Published online: 18 Jul 2017
AbstractforPEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia | Full Text | References | PDF (725.2 KB) | Supplemental
  • 859 Views
  • 13 CrossRef citations
  • 0Altmetric
Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies
AnnaLynn M. Williams, Andrea M. Baran, Philip J. Meacham, Megan M. Feldman, Hugo E. Valencia, Catherine Newsom-Stewart, Nealansh Gupta, Michelle C. Janelsins, Paul M. Barr & Clive S. Zent
Pages: 625-632
Published online: 11 Jul 2017
AbstractforAnalysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies | Full Text | References | PDF (611.2 KB) | Supplemental
  • 1114 Views
  • 49 CrossRef citations
  • 0Altmetric
Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia
Isabel González-Gascón y Marín, María Hernández-Sanchez, Ana Eugenia Rodríguez-Vicente, Anna Puiggros, Rosa Collado, Elisa Luño, Teresa González, Neus Ruiz-Xivillé, Margarita Ortega, Eva Gimeno, Carolina Muñoz, Maria Stefania Infante, Julio Delgado, María Teresa Vargas, Marcos González, Francesc Bosch, Blanca Espinet, Jesús María Hernández-Rivas, José Ángel Hernández & On behalf of Grupo Español de Leucemia Linfática Crónica (GELLC) and Grupo Cooperativo Español de Citogenética Hematológica (GCECGH)
Pages: 633-642
Published online: 21 Jul 2017
AbstractforCharacterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia | Full Text | References | PDF (1.1 MB) | Supplemental
  • 309 Views
  • 8 CrossRef citations
  • 0Altmetric
Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval length
Eric M. Ammann, Tait D. Shanafelt, Kara B. Wright, Bradley D. McDowell, Brian K. Link & Elizabeth A. Chrischilles
Pages: 643-649
Published online: 18 Jul 2017
AbstractforUpdating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval length | Full Text | References | PDF (1.1 MB) | Supplemental
  • 368 Views
  • 9 CrossRef citations
  • 0Altmetric

Original Articles: Research

Arsenic trioxide decreases the amount and inhibits the function of regulatory T cells, which may contribute to its efficacy in the treatment of acute promyelocytic leukemia
Wen Xu, Xiaoxia Li, Lina Quan, Jiying Yao, Guannan Mu, Jingjie Guo & Yitong Wang
Pages: 650-659
Published online: 06 Jul 2017
AbstractforArsenic trioxide decreases the amount and inhibits the function of regulatory T cells, which may contribute to its efficacy in the treatment of acute promyelocytic leukemia | Full Text | References | PDF (2.7 MB) | Supplemental
  • 166 Views
  • 7 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Can the SUVmax-liver-based interpretation improve prognostic accuracy of interim and posttreatment 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma?
Yuewei Zhang, Yang Fan, Zhitao Ying, Yuqin Song, Jun Zhu, Zhi Yang & Xuejuan Wang
Pages: 660-669
Published online: 03 Aug 2017
AbstractforCan the SUVmax-liver-based interpretation improve prognostic accuracy of interim and posttreatment 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma? | Full Text | References | PDF (1.2 MB) | Supplemental
  • 341 Views
  • 16 CrossRef citations
  • 0Altmetric
Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphoma
Wojciech Jurczak, Sundra Ramanathan, Pratyush Giri, Alessandra Romano, Heidi Mocikova, Jill Clancy, Mariajose Lechuga, Michelle Casey, Joseph Boni, Agnieszka Giza & Georg Hess
Pages: 670-678
Published online: 03 Aug 2017
AbstractforComparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphoma | Full Text | References | PDF (856.8 KB) | Supplemental
  • 1375 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Low Rap1-interacting factor 1 and sirtuin 6 expression predict poor outcome in radiotherapy-treated Hodgkin lymphoma patients
Hamid Bur, Kirsi-Maria Haapasaari, Taina Turpeenniemi-Hujanen, Outi Kuittinen, Päivi Auvinen, Katja Marin, Ylermi Soini & Peeter Karihtala
Pages: 679-689
Published online: 08 Aug 2017
AbstractforLow Rap1-interacting factor 1 and sirtuin 6 expression predict poor outcome in radiotherapy-treated Hodgkin lymphoma patients | Full Text | References | PDF (2.3 MB) | Supplemental
  • 167 Views
  • 3 CrossRef citations
  • 0Altmetric
A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma
Brian T. Hill, Mitchell R. Smith, Meredeth Shelley, Deepa Jagadeesh, Robert M. Dean, Brad Pohlman, John W. Sweetenham, Brian J. Bolwell & Stephen D. Smith
Pages: 690-694
Published online: 11 Jul 2017
AbstractforA phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma | Full Text | References | PDF (457.6 KB) | Supplemental
  • 201 Views
  • 3 CrossRef citations
  • 0Altmetric

Original Articles: Research

Variability of performance status assessment between patients with hematologic malignancies and their physicians
Alexis D. Leal, Cristine Allmer, Matthew J. Maurer, Tait D. Shanafelt, James R. Cerhan, Brian K. Link & Carrie A. Thompson
Pages: 695-701
Published online: 18 Jul 2017
AbstractforVariability of performance status assessment between patients with hematologic malignancies and their physicians | Full Text | References | PDF (547.1 KB) | Supplemental
  • 231 Views
  • 10 CrossRef citations
  • 0Altmetric
Alternative splicing of hTERT: a further mechanism for the control of active hTERT in acute myeloid leukemia
Celeste Calvello, Barbara Rocca, Catherine Klersy, Rita Zappatore, Ilaria Giardini, Irene Dambruoso, Francesca Pasi, Marilena Caresana, Patrizia Zappasodi, Rosanna Nano, Marina Boni & Paolo Bernasconi
Pages: 702-709
Published online: 06 Jul 2017
AbstractforAlternative splicing of hTERT: a further mechanism for the control of active hTERT in acute myeloid leukemia | Full Text | References | PDF (743.8 KB) | Supplemental
  • 242 Views
  • 4 CrossRef citations
  • 0Altmetric
The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma
Katalin Piroska Kiss, Gergely Varga, Gabor Mikala, Katalin Balassa, Andras Bors, Petra Kovy, Nora Meggyesi, Andras Kozma, Otto Csacsovszki, Peter Remenyi, Istvan Valyi-Nagy, Attila Tordai, Tamas Masszi & Hajnalka Andrikovics
Pages: 710-716
Published online: 09 Jul 2017
AbstractforThe adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma | Full Text | References | PDF (1.6 MB) | Supplemental
  • 182 Views
  • 1 CrossRef citations
  • 0Altmetric
Autoantibodies against β1-adrenergic receptor: response to induction therapy with bortezomib-containing regimens for multiple myeloma patients
Wen Gao, Wen-Jia Guo, Dong-Yan Hou, Guang-Zhong Yang, Yin Wu, Yan-Chen Li, Yun Leng, Yu Tang, Lin Xu, Jia-Mei Liu, Hua Wang, Xin Wang, Juan Zhang, Wen-Shu Zhao, Wen-Ming Chen & Lin Zhang
Pages: 717-724
Published online: 06 Jul 2017
AbstractforAutoantibodies against β1-adrenergic receptor: response to induction therapy with bortezomib-containing regimens for multiple myeloma patients | Full Text | References | PDF (944.9 KB) | Supplemental
  • 156 Views
  • 1 CrossRef citations
  • 0Altmetric
Chimeric NUP98–NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemia
Jarno L. Kivioja, Jesus M. Lopez Martí, Ashwini Kumar, Mika Kontro, Henrik Edgren, Alun Parsons, Tuija Lundán, Maija Wolf, Kimmo Porkka & Caroline A. Heckman
Pages: 725-732
Published online: 04 Aug 2017
AbstractforChimeric NUP98–NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemia | Full Text | References | PDF (1.6 MB) | Supplemental
  • 2894 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment
Ekaterina Chelysheva, Anna Turkina, Evgenia Polushkina, Roman Shmakov, Alexey Zeifman, Sergey Aleshin, Igor Shokhin, Dorel Guranda, Oksana Oksenjuk, Sergey Mordanov, Khamida Kazakbaeva & Ghermes Chilov
Pages: 733-738
Published online: 13 Jul 2017
AbstractforPlacental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment | Full Text | References | PDF (537.6 KB) | Supplemental
  • 572 Views
  • 21 CrossRef citations
  • 0Altmetric

Letters to the Editor

Ibrutinib therapy is effective in B-cell prolymphocytic leukemia exhibiting MYC aberrations
Moussab Damlaj, Mohammed Al Balwi & Areej M. Al Mugairi
Pages: 739-742
Published online: 11 Jul 2017
First Page PreviewforIbrutinib therapy is effective in B-cell prolymphocytic leukemia exhibiting MYC aberrations | Full Text | References | PDF (881.2 KB) | Supplemental
  • 472 Views
  • 6 CrossRef citations
  • 0Altmetric
Spontaneous remission of acute myeloid leukemia after discontinuation of lenalidomide
Brandon Kremer, Donald E. Tsai, Fotini Debonera, Patti L. Cohen & Stephen J. Schuster
Pages: 743-745
Published online: 11 Jul 2017
First Page PreviewforSpontaneous remission of acute myeloid leukemia after discontinuation of lenalidomide | Full Text | References | PDF (867.7 KB) | Supplemental
  • 221 Views
  • 3 CrossRef citations
  • 0Altmetric
Successful preemptive donor lymphocyte infusions from a haploidentical donor in a boy with E2A-HLF-positive ALL
Maiko Hirai, Hiroshi Yagasaki, Junya Fujimura, Masami Inoue, Katsuyoshi Shimozawa, Hirotsugu Okuma, Motoaki Chin & Shori Takahashi
Pages: 746-748
Published online: 21 Jul 2017
First Page PreviewforSuccessful preemptive donor lymphocyte infusions from a haploidentical donor in a boy with E2A-HLF-positive ALL | Full Text | References | PDF (408.7 KB) | Supplemental
  • 227 Views
  • 5 CrossRef citations
  • 0Altmetric
Cytomegalovirus antigenemia and end-organ disease in Japanese patients treated with bendamustine
Akira Chiba, Fumihiko Nakamura, Kumi Nakazaki & Mineo Kurokawa
Pages: 749-751
Published online: 12 Jul 2017
First Page PreviewforCytomegalovirus antigenemia and end-organ disease in Japanese patients treated with bendamustine | Full Text | References | PDF (303.3 KB) | Supplemental
  • 293 Views
  • 4 CrossRef citations
  • 0Altmetric
Chronic lymphocytic leukemia in a patient with well-controlled HIV infection: successful treatment with ibrutinib
James T. England & Heather A. Leitch
Pages: 752-754
Published online: 21 Jul 2017
First Page PreviewforChronic lymphocytic leukemia in a patient with well-controlled HIV infection: successful treatment with ibrutinib | Full Text | References | PDF (336.9 KB) | Supplemental
  • 256 Views
  • 1 CrossRef citations
  • 0Altmetric
Clinical evaluation of combined azacitidine and entinostat on the induction of fetal hemoglobin in patients with acute myeloid leukemias and myelodysplastic syndromes
Katharine R. Press, Natalie Uy, Jeffrey Keefer, Steven D. Gore, Hetty E. Carraway, Sarah Sakoian & Thomas Prebet
Pages: 755-757
Published online: 25 Jul 2017
First Page PreviewforClinical evaluation of combined azacitidine and entinostat on the induction of fetal hemoglobin in patients with acute myeloid leukemias and myelodysplastic syndromes | Full Text | References | PDF (525.8 KB) | Supplemental
  • 202 Views
  • 3 CrossRef citations
  • 0Altmetric
Does double-hit follicular lymphoma with translocations of MYC and BCL2 change the definition of transformation?
Hiroki Katsushima, Noriko Fukuhara, Sachiko Konosu-Fukaya, Masahito Himuro, Yuko Kitawaki, Satoshi Ichikawa, Kenichi Ishizawa, Hironobu Sasano, Hideo Harigae & Ryo Ichinohasama
Pages: 758-762
Published online: 03 Aug 2017
First Page PreviewforDoes double-hit follicular lymphoma with translocations of MYC and BCL2 change the definition of transformation? | Full Text | References | PDF (1.7 MB) | Supplemental
  • 482 Views
  • 4 CrossRef citations
  • 0Altmetric
Successful treatment of a patient with acute promyelocytic leukemia with a STAT5B/RARA fusion gene using decitabine
Anyou Wang, Xiaoyan Cai, Ping Qiang & Qiaohong Duan
Pages: 763-765
Published online: 01 Aug 2017
First Page PreviewforSuccessful treatment of a patient with acute promyelocytic leukemia with a STAT5B/RARA fusion gene using decitabine | Full Text | References | PDF (375.4 KB) | Supplemental
  • 231 Views
  • 9 CrossRef citations
  • 0Altmetric
Sustained molecular response in chronic myeloid leukemia deep responders treated with low dose tyrosine kinase inhibitors
Emilie Cayssials, Florence Tartarin, Joëlle Guilhot, Nathalie Sorel, Jean Claude Chomel, Xavier Leleu & François Guilhot
Pages: 766-769
Published online: 09 Aug 2017
First Page PreviewforSustained molecular response in chronic myeloid leukemia deep responders treated with low dose tyrosine kinase inhibitors | Full Text | References | PDF (409.3 KB) | Supplemental
  • 186 Views
  • 4 CrossRef citations
  • 0Altmetric

Correspondence

Diagnostic value of serum ferritin and cytokine profiles of hemophagocytic syndrome following allogeneic hematopoietic cell transplantation: methodological issues
Siamak Sabour
Pages: 770-771
Published online: 23 May 2017
CitationforDiagnostic value of serum ferritin and cytokine profiles of hemophagocytic syndrome following allogeneic hematopoietic cell transplantation: methodological issues | Full Text | References | PDF (335 KB) | Supplemental
  • 74 Views
  • 2 CrossRef citations
  • 0Altmetric
Diagnostic value of serum ferritin and cytokine profiles of hemophagocytic syndrome following allogeneic hematopoietic cell transplantation: methodological issues
Hideo Koh, Satoru Nanno, Masayuki Hino & Hirohisa Nakamae
Pages: 772-773
Published online: 04 Aug 2017
CitationforDiagnostic value of serum ferritin and cytokine profiles of hemophagocytic syndrome following allogeneic hematopoietic cell transplantation: methodological issues | Full Text | References | PDF (233.5 KB) | Supplemental
  • 72 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles